Our finding revealed deregulation of PI3K/AKT signaling pathway, EGFR tyrosine kinase inhibitor resistance, non-small cell lung cancer and osteoclast differentiaton in ALK-positive lung cancer. This evidence concerns the gene PIK3CA and non-small cell lung carcinoma.